Infrastructure teams supporting diagnostics companies tend to inherit an odd workload. On paper it looks like any other research environment: instrument output, analysis pipelines, a LIMS, some cloud storage, and a lot of spreadsheets. In practice, every result that might end up in an FDA submission carries a long tail of context that has to survive for years. That context is where most of the hard architectural decisions live. In vitro diagnostic (IVD) developers test …